Back to Results
First PageMeta Content
Pharmacology / Clinical research / Medicinal chemistry / Astex / Fibroblast growth factor receptor 1 / Fibroblast growth factor receptor / Tyrosine kinase / Fibroblast growth factor / Protein kinase / Pharmaceutical sciences / Biology / Tyrosine kinase receptors


Astex To Present Data From Its FGFR Inhibitor Programme at the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 Cambridge, UK, 29th March[removed]Astex Therapeutics, the UK-based biotechnology comp
Add to Reading List

Open Document

File Size: 13,70 KB

Share Result on Facebook

City

Orlando / Cambridge / Beerse / /

Company

GlaxoSmithKline / Johnson & Johnson / Bayer / Novartis / Astex Therapeutics Astex / Astex Therapeutics / Schering / Boehringer Ingelheim / Cancer Research UK Drug Discovery Group / AstraZeneca / Janssen Pharmaceutica / /

Country

Belgium / United States / United Kingdom / /

Currency

USD / /

/

Event

Business Partnership / /

Facility

Newcastle Cancer Centre / Orange County Convention Center / Newcastle University / Northern Institute / /

IndustryTerm

biotechnology / pharmaceutical / /

MedicalCondition

cancer / tumour / /

Organization

3Newcastle Cancer Centre / Newcastle University / Newcastle Cancer Centre / /

Person

Jeremy Carmichael / /

/

Position

Author / Director of Business Development Tel / /

ProvinceOrState

Florida / /

PublishedMedium

Cancer Research / /

Technology

drug discovery / X-ray / Drug Design / /

URL

www.astex-therapeutics.com / /

SocialTag